1st Biotech IPO Since February: LB Pharma Upsizes Deal
LB Pharma is set to upsize its initial public offering, marking the 1st biotech listing since February and signaling potential renewed investor confidence.
LB Pharma is set to upsize its initial public offering, marking the 1st biotech listing since February and signaling potential renewed investor confidence.
Explore the curious SPAC deal taking nuclear startup Deep Fission public. We analyze the risks, rewards, and what this move means for the future of the energy sector.